Peregrine Pharmaceuticals | Capitale Di Prestito



Loan Capital Cambiamento Data
Amgen USD 54.01B 2.54B 2025-03
AstraZeneca USD 27.89B 154M 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Celldex Therapeutics USD 0 0 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
MacroGenics USD 0 0 2024-12
MannKind USD 231.08M 36.2M 2025-03
Merck USD 33.48B 978M 2025-03
Novartis USD 22.93B 2.41B 2024-12
Repligen USD 529.6M 4.04M 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Xencor USD 101.84M 13.32M 2025-03



Peregrine Pharmaceuticals Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.